Skip to main content
Fig. 1 | BMC Neurology

Fig. 1

From: The Promotoer, a brain-computer interface-assisted intervention to promote upper limb functional motor recovery after stroke: a study protocol for a randomized controlled trial to test early and long-term efficacy and to identify determinants of response

Fig. 1

Promotoer trial summary. All admitted participants (approximately 2400 along the course of two years) will be screened (T(− 1)) for eligibility according to I/E (Inclusion/Exclusion) criteria. The FMA/60 (Fugl-Meyer Assessment, upper limb section, without the 6 points relative to the reflexes [20];) and the TT (Token Test) to verify the participants ability to understand the task, will be used for Eligibility and Stratification. Eligible participants will be presented with the Informed Consent and recruited (48 participants). After recruitment, screening evaluation (T(− 1)) will be completed with the execution of MEP (Motor Evoked Potentials, upper limbs) and other neuropsychological tests (TMT - Trial Making Test; TAP - Test of Attentional Performance). Clinical functional outcome variables will be assessed at T0, T1, T2, T3 and T4. EEG (electroencephalogram) will also be performed at T0, T1, T2, T3 and T4. MRI (Magnetic Resonance Imaging) scan of the whole brain will be performed at T0, T3 and T4. Enrolment, Randomization, Training and Evaluations up to T1 will be performed while participants are admitted for rehabilitation. Subsequent evaluations (T2, T3, T4) will most likely occur at discharge (post-admission) and will be preceded by a phone call to check participants status and to set appointments

Back to article page